Blade Air Mobility, Inc. engages in providing air transportation alternatives through a technology-powered and global air mobility platform. The company is headquartered in New York City, New York and currently employs 310 full-time employees. The company went IPO on 2019-09-17. The firm transports human organs for transplant, and for passengers, with helicopter and fixed wing services primarily in the Northeast United States and Southern Europe. The company operates in three key product lines across its Passenger and Medical segments. Its Passenger segment includes Short Distance and Jet and Other. Short Distance business consists of helicopter and amphibious seaplane flights in the United States and Europe. Jet and Other business consists of non-medical jet charter and brand partners for exposure to Blade fliers and certain ground transportation services. Its Medical segment includes MediMobility Organ Transport, which consists of the transportation of human organs for transplant and/or the medical teams supporting these services. The company also offers additional services including donor logistics coordination and support for evaluating potential donor organs.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2026
12/31/2025
09/30/2025
06/30/2025
03/31/2025
Revenue
254
67
66
49
70
54
Revenue Growth (YoY)
20%
24%
22%
36%
4%
6%
Cost of Revenue
355
53
211
37
53
42
Gross Profit
-100
14
-144
11
17
11
Selling, General & Admin
112
15
58
16
21
18
Research & Development
--
--
--
--
--
--
Operating Expenses
-80
17
62
17
22
19
Other Non Operating Income (Expenses)
5
4
0
0
0
2
Pretax Income
-16
2
-5
-9
-3
-3
Income Tax Expense
0
0
0
0
0
0
Net Income
46
2
-8
57
-3
-3
Net Income Growth
-277%
-167%
-11%
-5,800%
-73%
-25%
Shares Outstanding (Diluted)
90.16
90.16
84.69
82.45
81.29
79.89
Shares Change (YoY)
13%
13%
8%
6%
5%
5%
EPS (Diluted)
0.52
0.02
-0.1
0.69
-0.05
-0.04
EPS Growth
-258%
-167%
-17%
-3,550%
-67%
-33%
Free Cash Flow
-58
-1
-10
-40
-5
-3
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
-39.37%
20.89%
-218.18%
22.44%
24.28%
20.37%
Operating Margin
-7.48%
-2.98%
-312.12%
-10.2%
-5.71%
-12.96%
Profit Margin
18.11%
2.98%
-12.12%
116.32%
-4.28%
-5.55%
Free Cash Flow Margin
-22.83%
-1.49%
-15.15%
-81.63%
-7.14%
-5.55%
EBITDA
-10
1
-203
-4
-3
-6
EBITDA Margin
-3.93%
1.49%
-307.57%
-8.16%
-4.28%
-11.11%
D&A For EBITDA
9
3
3
1
1
1
EBIT
-19
-2
-206
-5
-4
-7
EBIT Margin
-7.48%
-2.98%
-312.12%
-10.2%
-5.71%
-12.96%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Strata Critical Medical Inc's key financial statements?
According to the latest financial statement (Form-10K), Strata Critical Medical Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for SRTA?
Strata Critical Medical Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Strata Critical Medical Inc's revenue broken down by segment or geography?
Strata Critical Medical Inc largest revenue segment is Investment Management Fee, at a revenue of 6,981,800,000 in the most earnings release.For geography, United States is the primary market for Strata Critical Medical Inc, at a revenue of 6,614,200,000.
Is Strata Critical Medical Inc profitable?
no, according to the latest financial statements, Strata Critical Medical Inc has a net loss of $0
Does Strata Critical Medical Inc have any liabilities?
no, Strata Critical Medical Inc has liability of 0
How many outstanding shares for Strata Critical Medical Inc?
Strata Critical Medical Inc has a total outstanding shares of 0